Mylan CEO Behind EpiPen Price Furor Praised by Senator Father
- Manchin distances himself from drugmaker but praises Bresch
- Some outraged colleagues want hearings and investigations
Mylan Plans Half-Priced Generic Version of EpiPen
This article is for subscribers only.
West Virginia Senator Joe Manchin admits he’s a proud father seeing his daughter run a drug company, but he says he didn’t know much about the business decisions Mylan NV made as it raised prices more than 400 percent on the EpiPen -- and kept it that way on purpose.
Heather Bresch, Manchin’s daughter and Mylan’s chief executive officer, has come under fire from lawmakers, including many of his fellow Democrats, for her pricing decisions on the life-saving anti-allergy drug.